pubmed-article:12228791 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C0026266 | lld:lifeskim |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C0040961 | lld:lifeskim |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C1277187 | lld:lifeskim |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
pubmed-article:12228791 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:12228791 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:12228791 | pubmed:dateCreated | 2002-9-13 | lld:pubmed |
pubmed-article:12228791 | pubmed:abstractText | Mitral regurgitation (MR) and tricuspid regurgitation (TR) frequently develop in patients with left ventricular systolic dysfunction (LVSD). Ventricular volume overload that occurs in patients with MR and TR may lead to progression of myocardial dysfunction. We hypothesized that MR and TR would provide markers of risk in patients with LVSD. | lld:pubmed |
pubmed-article:12228791 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12228791 | pubmed:language | eng | lld:pubmed |
pubmed-article:12228791 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12228791 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12228791 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12228791 | pubmed:month | Sep | lld:pubmed |
pubmed-article:12228791 | pubmed:issn | 1097-6744 | lld:pubmed |
pubmed-article:12228791 | pubmed:author | pubmed-author:ArmstrongWill... | lld:pubmed |
pubmed-article:12228791 | pubmed:author | pubmed-author:KoellingTodd... | lld:pubmed |
pubmed-article:12228791 | pubmed:author | pubmed-author:CodyRobert... | lld:pubmed |
pubmed-article:12228791 | pubmed:author | pubmed-author:AaronsonKeith... | lld:pubmed |
pubmed-article:12228791 | pubmed:author | pubmed-author:BachDavid SDS | lld:pubmed |
pubmed-article:12228791 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:12228791 | pubmed:volume | 144 | lld:pubmed |
pubmed-article:12228791 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12228791 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12228791 | pubmed:pagination | 524-9 | lld:pubmed |
pubmed-article:12228791 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:meshHeading | pubmed-meshheading:12228791... | lld:pubmed |
pubmed-article:12228791 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12228791 | pubmed:articleTitle | Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. | lld:pubmed |
pubmed-article:12228791 | pubmed:affiliation | Division of Cardiology, Department of Internal Medicine, the University of Michigan, Ann Arbor, Mich, USA. tkoellin@umich.edu | lld:pubmed |
pubmed-article:12228791 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12228791 | lld:pubmed |